DIESE MELDUNG PER E-MAIL VERSENDEN
HiST Pharma Announces U.S. FDA Approval to Initiate Phase III Clinical Study With TC Cream – World’s First Botanical Small-Molecule Drug That Treats Psoriasis Vulgaris
*
marks required fields
Name des Empfängers:
*
E-Mail des Empfängers:
Nachricht:
*
Enter security words: